Hongwei He

2.3k total citations
97 papers, 1.9k citations indexed

About

Hongwei He is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Hongwei He has authored 97 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 32 papers in Hepatology and 29 papers in Oncology. Recurrent topics in Hongwei He's work include Liver physiology and pathology (27 papers), Liver Disease Diagnosis and Treatment (24 papers) and Drug Transport and Resistance Mechanisms (12 papers). Hongwei He is often cited by papers focused on Liver physiology and pathology (27 papers), Liver Disease Diagnosis and Treatment (24 papers) and Drug Transport and Resistance Mechanisms (12 papers). Hongwei He collaborates with scholars based in China, United States and United Kingdom. Hongwei He's co-authors include Rong‐Guang Shao, Wuli Zhao, Shi‐Ying Cai, Mao‐xu Ge, James L. Boyer, Albert Mennone, Shenghua Zhang, Dongke Yu, Cai‐Xia Zhang and Hong Liu and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Biochemistry.

In The Last Decade

Hongwei He

95 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hongwei He China	27	888	477	397	395	213	97	1.9k
Raymond Wu United States	17	1.1k 1.2×	416 0.9×	146 0.4×	145 0.4×	226 1.1×	24	1.9k
Chang Han United States	28	1.2k 1.3×	418 0.9×	469 1.2×	203 0.5×	519 2.4×	61	2.5k
Ling Xu China	33	1.5k 1.6×	620 1.3×	374 0.9×	414 1.0×	759 3.6×	92	2.8k
Manon Buist‐Homan Netherlands	20	535 0.6×	481 1.0×	222 0.6×	301 0.8×	97 0.5×	58	1.4k
Lionel Hebbard Australia	32	1.2k 1.4×	1.1k 2.2×	489 1.2×	326 0.8×	499 2.3×	51	2.7k
Karsten Gülow Germany	23	1.0k 1.1×	323 0.7×	240 0.6×	104 0.3×	271 1.3×	57	2.1k
David G. Breckenridge United States	21	1.7k 1.9×	682 1.4×	220 0.6×	182 0.5×	148 0.7×	40	2.5k
Rajgopal Govindarajan United States	26	883 1.0×	197 0.4×	539 1.4×	71 0.2×	276 1.3×	49	2.1k
Wolfgang Hagmann Germany	23	626 0.7×	177 0.4×	637 1.6×	182 0.5×	245 1.2×	49	2.1k

Countries citing papers authored by Hongwei He

Since Specialization

Citations

This map shows the geographic impact of Hongwei He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei He more than expected).

Fields of papers citing papers by Hongwei He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongwei He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei He. The network helps show where Hongwei He may publish in the future.

Co-authorship network of co-authors of Hongwei He

This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei He. A scholar is included among the top collaborators of Hongwei He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei He. Hongwei He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Can, Jie Jack Li, Hongwei He, et al.. (2025). In vivo safety prediction of recombinant collagen using in vitro simulated degradation analysis, chronic toxicity and immunological evaluation. Regenerative Biomaterials. 13. rbaf128–rbaf128.

Guo, Simin, Yongjian Wang, Yiming Li, et al.. (2024). Synthesis and Anti-Liver Fibrosis Research of Aspartic Acid Derivatives. Molecules. 29(19). 4774–4774. 2 indexed citations

Zhang, Na, Yiming Li, Simin Guo, et al.. (2024). Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway. Journal of Pharmaceutical Analysis. 15(3). 101048–101048. 2 indexed citations

Ma, Hao, Shuaishuai Niu, Shaorong Wang, et al.. (2023). Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy. Pharmaceuticals. 16(5). 758–758. 5 indexed citations

Zhang, Na, Tianyun Fan, Yanxiang Wang, et al.. (2023). Evolution and Discovery of Matrine Derivatives as a New Class of Anti-Hepatic Fibrosis Agents Targeting Ewing Sarcoma Breakpoint Region 1 (EWSR1). Journal of Medicinal Chemistry. 66(12). 7969–7987. 3 indexed citations

He, Hongwei, et al.. (2023). Short- and Long-Term Outcomes in Laparoscopic Versus Open Hepatectomy for Hepatocellular Carcinoma in Elderly Patients: A Systematic Review and Meta-Analysis. Journal of Laparoendoscopic & Advanced Surgical Techniques. 33(4). 321–334. 2 indexed citations

Zhang, Na, Tianyun Fan, Liping Zhao, et al.. (2022). Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR). European Journal of Medicinal Chemistry. 245(Pt 1). 114886–114886. 10 indexed citations

Zhang, Qian, Yuzhuo Wu, Mao‐xu Ge, et al.. (2022). Paeoniflorin-free subfraction of Paeonia lactiflora Pall. shows the potential of anti-hepatic fibrosis: an integrated analysis of network pharmacology and experimental validation. Journal of Ethnopharmacology. 299. 115678–115678. 12 indexed citations

Niu, Xia, et al.. (2022). New IMB16-4 Nanoparticles Improved Oral Bioavailability and Enhanced Anti-Hepatic Fibrosis on Rats. Pharmaceuticals. 15(1). 85–85. 5 indexed citations

10.

Song, Yonggui, Yali Liu, Hongwei He, et al.. (2022). Study on the mechanism of reducing biofilm toxicity and increasing antioxidant activity in vinegar processing phytomedicines containing pentacyclic triterpenoid saponins. Journal of Ethnopharmacology. 290. 115112–115112. 14 indexed citations

11.

Song, Yonggui, Baixi Shan, Jie Zhang, et al.. (2020). Raw and wine processed Schisandra chinensis attenuate anxiety like behavior via modulating gut microbiota and lipid metabolism pathway. Journal of Ethnopharmacology. 266. 113426–113426. 59 indexed citations

12.

Zhang, Na, Shuangshuang Zhao, Yucheng Wang, et al.. (2020). A novel biphenyl compound IMB-S7 ameliorates hepatic fibrosis in BDL rats by suppressing Sp1-mediated integrin αv expression. Acta Pharmacologica Sinica. 41(5). 661–669. 11 indexed citations

13.

Ge, Mao‐xu, Rong‐Guang Shao, & Hongwei He. (2019). Advances in understanding the regulatory mechanism of cholesterol 7α-hydroxylase. Biochemical Pharmacology. 164. 152–164. 31 indexed citations

14.

Wang, Meng‐Yan, Cong-Hui Zhang, Junxia Wang, et al.. (2019). Role of co- and post-translational modifications of SFKs in their kinase activation. Journal of drug targeting. 28(1). 23–32. 1 indexed citations

15.

Zhao, Shuangshuang, Yong‐Zhan Zhen, Mao‐xu Ge, et al.. (2015). Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats. Food and Chemical Toxicology. 86. 202–207. 32 indexed citations

16.

Zhang, Cai‐Xia, et al.. (2014). [Inhibitions of SphK1 inhibitor SKI II on cell cycle progression and cell invasion of hepatoma HepG2 cells].. PubMed. 49(2). 204–8. 1 indexed citations

17.

Chen, Yi, Dongke Yu, Caixia Zhang, et al.. (2013). Lidamycin inhibits tumor initiating cells of hepatocellular carcinoma Huh7 through GSK3β/β‐catenin pathway. Molecular Carcinogenesis. 54(1). 1–8. 19 indexed citations

18.

Zhang, Cai‐Xia, Hongwei He, & Rong‐Guang Shao. (2013). [Sphingosine kinase 1 and tumor].. PubMed. 48(7). 971–8. 4 indexed citations

19.

Zhang, Shenghua, Hao Zhang, Hongwei He, et al.. (2013). Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma. Cancer Chemotherapy and Pharmacology. 72(4). 777–788. 7 indexed citations

20.

Zhang, Hao, Shenghua Zhang, Hongwei He, et al.. (2012). GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin‐mediated cytotoxicity to colon carcinoma HCT116 cells. Cancer Science. 103(10). 1848–1856. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact